SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors

被引：0
|
作者：
C. Kratochwil
M. Stefanova
E. Mavriopoulou
T. Holland-Letz
A. Dimitrakopoulou-Strauss
A. Afshar-Oromieh
W. Mier
U. Haberkorn
F. L. Giesel
机构：
[1] University Hospital Heidelberg,Department of Nuclear Medicine
[2] German Cancer Research Center,Department of Biostatistics
[3] German Cancer Research Center,KKE Nuclear Medicine
来源：
Molecular Imaging and Biology | 2015年 / 17卷
关键词：
Neuroendocrine tumors; Peptide-related radionuclide therapy; [; Ga]DOTATOC; Somatostatin receptor; SUV;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：313 / 318
页数：5
相关论文
共 50 条
  • [31] Detectability of PET/CT with 68Ga-DOTATOC for identifying suspected or unknown primary neuroendocrine tumors
    Nakamoto, Yuji
    Sano, Kohei
    Nakatani, Koya
    Arimoto, Maya
    Nobashi, Tomomi
    Togashi, Kaori
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [32] Robustness of Radiomic Features in 68Ga-DOTATOC PET/CT: A Monocentric Experience for Neuroendocrine Tumors
    Liberini, V
    De Santi, B.
    Gaffio, E.
    Rampado, O.
    Dionisi, B.
    Ceci, F.
    Zotta, M.
    Giunta, F.
    Finessi, M.
    Bello, M.
    Molinari, F.
    Deandreis, D.
    NEUROENDOCRINOLOGY, 2020, 110 : 263 - 263
  • [33] Impact of Multiphase 68Ga-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors
    Ruf, Juri
    Heuck, Friederike
    Schiefer, Jan
    Denecke, Timm
    Elgeti, Florian
    Pascher, Andreas
    Pavel, Marianne
    Stelter, Lars
    Kropf, Siegfried
    Wiedenmann, Bertram
    Amthauer, Holger
    NEUROENDOCRINOLOGY, 2010, 91 (01) : 101 - 109
  • [34] 68GA-DOTATOC PET/CT IMAGES REPRESENT THE CLINICAL CHARACTERISTICS OF PANCREATIC NEUROENDOCRINE TUMORS
    Kim, So Jeong
    Cha, Jongtae
    Lee, Hee Seung
    Chung, Moon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Song, Si Young
    Cho, Arthur
    Jo, Jung Hyun
    GASTROENTEROLOGY, 2023, 164 (06) : S323 - S324
  • [35] Clinical impact of Ga68-DOTATOC PET/CT on neuroendocrine tumors. A preliminary experience
    Lopez, Pedro Jose Plaza
    Pinera, Marina Suarez
    Fusco, Antoni Mestre
    Brasero, Beatriz Domenech
    Muntane, Paloma Pifarre
    Codias, Elisabet Rivera
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2020, 67 (10): : 636 - 642
  • [36] Quantitative 68Ga-DOTATOC PET/CT in Patients with Metastatic or Recurrent Neuroendocrine Tumors.
    Pampaloni, Miguel Hernandez
    Hope, Thomas
    Mari, Carina
    Nakakura, Eric
    VanBrocklin, Henry
    Slater, James
    Bergsland, Emily
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [37] Impact of Multiphase Ga-68-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors
    Ruf, J.
    Heuck, F.
    Schiefer, J.
    Denecke, T.
    Elgeti, F.
    Pascher, A.
    Pavel, M.
    Stelter, L.
    Kropf, S.
    Wiedenmann, B.
    Amthauer, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S346 - S346
  • [38] Detectability of PET/CT with 68Ga-DOTATOC for identifying suspected or unknown primary neuroendocrine tumors
    Nakamoto, Yuji
    Sano, Kohei
    Nakatani, Koya
    Arimoto, Maya
    Nobashi, Tomomi
    Togashi, Kaori
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [39] Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET
    Milker-Zabel, Stefanie
    Zabel-Du Bois, Angelika
    Henze, Marcus
    Huber, Peter
    Schulz-Ertner, Daniela
    Hoess, Angelika
    Haberkorn, Uwe
    Debus, Juergen
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (01): : 222 - 227
  • [40] Peribronchial Sclerosing Hemangioma With 68ga Uptakeof Dotatoc Pet-CT
    Kelly-Garcia, J.
    Cano Vargas, B. B.
    Criales-Cortes, J. L.
    Santiago-Payan, H.
    Canales-Ibarra, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
12345